Literature DB >> 11173646

Heterogeneous Expression of Invasive and Metastatic Properties in a Prostate Tumor Model.

Jan Luo1, Navesh Sharma, Elisabeth A Seftor, Joseph De Larco, Paul M Heidger, Mary J.C. Hendrix, David M Lubaroff.   

Abstract

Cellular heterogeneity of neoplasia is well demonstrated in the Dunning R-3327 rat prostate adenocarcinoma. In this study, we measured the differential expression of invasive and metastatic properties of this prostate model by cloning from a heterogeneous parental cell line. Four cell clones were derived and characterized by morphological studies, E-cadherin expression, and invasive and metastatic potential. Three of the clones (clones 5A, 5C, and 5D) demonstrated a fibroblastic morphology and were anchored to the substrate by loose microvillous processes. The fourth clone (clone 5B) grew in tight clusters and displayed many closely spaced microvilli, long overlapping cytoplasmic regions with well-defined junctional complexes. The parental line (R3327-5) demonstrated a combination of both these growth patterns. E-cadherin expression was absent in clones 5A, 5C, and 5D and very prominent in clone 5B, when compared to the parental line. The absence of E-cadherin expression correlated with increased invasiveness, as measured in an in vitro invasion assay. Subcutaneous injections of clones 5A, 5C, and 5D yielded lung metastases and no primary tumors at the site of inoculation while clone 5B was tumorigenic and produced fewer lung metastases in vivo. These clones, therefore, provide a potential for studying a variety of molecules involved in prostate cancer invasion and metastasis, especially for the direct testing of the significance of E-cadherin expresssion in prostate cancer progression.

Entities:  

Year:  1997        PMID: 11173646     DOI: 10.1007/bf02904285

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  21 in total

1.  PROSTATE CANCER IN THE RAT.

Authors:  W F DUNNING
Journal:  Natl Cancer Inst Monogr       Date:  1963-10

Review 2.  Cadherins: a molecular family important in selective cell-cell adhesion.

Authors:  M Takeichi
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

3.  Decreased expression of E-cadherin in the progression of rat prostatic cancer.

Authors:  M J Bussemakers; R J van Moorselaar; L A Giroldi; T Ichikawa; J T Isaacs; M Takeichi; F M Debruyne; J A Schalken
Journal:  Cancer Res       Date:  1992-05-15       Impact factor: 12.701

4.  Expression of E-cadherin in primary and metastatic prostate cancer.

Authors:  L Cheng; M Nagabhushan; T P Pretlow; S B Amini; T G Pretlow
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

5.  Thymosin beta 15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancer.

Authors:  L Bao; M Loda; P A Janmey; R Stewart; B Anand-Apte; B R Zetter
Journal:  Nat Med       Date:  1996-12       Impact factor: 53.440

6.  The loss of E-cadherin mRNA transcripts in rat prostatic tumors is accompanied by increased expression of mRNA transcripts encoding fibronectin and its receptor.

Authors:  C D MacCalman; P Brodt; J D Doublet; R Jednak; M M Elhilali; M Bazinet; O W Blaschuk
Journal:  Clin Exp Metastasis       Date:  1994-03       Impact factor: 5.150

7.  Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas.

Authors:  T Otto; W Birchmeier; U Schmidt; A Hinke; J Schipper; H Rübben; A Raz
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

8.  Characterization of the heterogeneity of R3327 rat prostatic tumors derived from single-cell clones.

Authors:  S A Thompson; M P Johnson; P M Heidger; D M Lubaroff
Journal:  Prostate       Date:  1985       Impact factor: 4.104

9.  E-cadherin expression in prostatic carcinoma biopsies: correlation with tumor grade, DNA content, pathologic stage, and clinical outcome.

Authors:  J S Ross; H L Figge; H X Bui; A D del Rosario; H A Fisher; T Nazeer; T A Jennings; R Ingle; D N Kim
Journal:  Mod Pathol       Date:  1994-10       Impact factor: 7.842

Review 10.  Cadherins in cancer: implications for invasion and metastasis.

Authors:  M Takeichi
Journal:  Curr Opin Cell Biol       Date:  1993-10       Impact factor: 8.382

View more
  7 in total

Review 1.  E-cadherin's dark side: possible role in tumor progression.

Authors:  Fausto J Rodriguez; Laura J Lewis-Tuffin; Panos Z Anastasiadis
Journal:  Biochim Biophys Acta       Date:  2012-03-13

Review 2.  The role of microRNA in castration-resistant prostate cancer.

Authors:  William Thieu; Derya Tilki; Ralph de Vere White; Christopher P Evans
Journal:  Urol Oncol       Date:  2014-07       Impact factor: 3.498

3.  Ral-regulated interaction between Sec5 and paxillin targets Exocyst to focal complexes during cell migration.

Authors:  Krystle S Spiczka; Charles Yeaman
Journal:  J Cell Sci       Date:  2008-08-12       Impact factor: 5.285

4.  E-cadherin re-expression shows in vivo evidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells.

Authors:  Katie Palen; James Weber; Michael B Dwinell; Bryon D Johnson; Ramani Ramchandran; Jill A Gershan
Journal:  Oncotarget       Date:  2016-07-12

5.  The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells.

Authors:  Reema A Ishteiwy; Toby M Ward; Derek M Dykxhoorn; Kerry L Burnstein
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

6.  Prostate Cancer Heterogeneous High-Metastatic Multi-Organ-Colonizing Chemo-Resistant Variants Selected by Serial Metastatic Passage in Nude Mice Are Highly Enriched for Multinucleate Giant Cells.

Authors:  Lei Zhang; Chengyu Wu; Robert M Hoffman
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

7.  Cytoplasmic cyclin D1 regulates cell invasion and metastasis through the phosphorylation of paxillin.

Authors:  Noel P Fusté; Rita Fernández-Hernández; Tània Cemeli; Cristina Mirantes; Neus Pedraza; Marta Rafel; Jordi Torres-Rosell; Neus Colomina; Francisco Ferrezuelo; Xavier Dolcet; Eloi Garí
Journal:  Nat Commun       Date:  2016-05-16       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.